Creative Planning’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,400
| Closed | -$101K | – | 2159 |
|
|
2021
Q2 | $101K | Sell |
10,400
-10,650
| -51% | -$103K | ﹤0.01% | 1857 |
|
|
2021
Q1 | $226K | Sell |
21,050
-24,758
| -54% | -$266K | ﹤0.01% | 1962 |
|
|
2020
Q4 | $674K | Buy |
45,808
+27,212
| +146% | +$400K | ﹤0.01% | 1132 |
|
|
2020
Q3 | $264K | Buy |
18,596
+6,371
| +52% | +$90.4K | ﹤0.01% | 1481 |
|
|
2020
Q2 | $99K | Buy |
+12,225
| New | +$99K | ﹤0.01% | 1641 |
|
|
2018
Q4 | – | Sell |
-29,300
| Closed | -$170K | – | 1967 |
|
|
2018
Q3 | $170K | Sell |
29,300
-100
| -0.3% | -$580 | ﹤0.01% | 1694 |
|
|
2018
Q2 | $176K | Buy |
29,400
+1,000
| +4% | +$5.99K | ﹤0.01% | 1655 |
|
|
2018
Q1 | $204K | Buy |
28,400
+2,000
| +8% | +$14.4K | ﹤0.01% | 1595 |
|
|
2017
Q4 | $191K | Hold |
26,400
| – | – | ﹤0.01% | 1611 |
|
|
2017
Q3 | $136K | Hold |
26,400
| – | – | ﹤0.01% | 1664 |
|
|
2017
Q2 | $116K | Buy |
26,400
+300
| +1% | +$1.32K | ﹤0.01% | 1877 |
|
|
2017
Q1 | $161K | Hold |
26,100
| – | – | ﹤0.01% | 1619 |
|
|
2016
Q4 | $147K | Buy |
26,100
+18,000
| +222% | +$101K | ﹤0.01% | 1580 |
|
|
2016
Q3 | $120K | Buy |
8,100
+2,200
| +37% | +$32.6K | ﹤0.01% | 1714 |
|
|
2016
Q2 | $53K | Buy |
5,900
+5,800
| +5,800% | +$52.1K | ﹤0.01% | 2097 |
|
|
2016
Q1 | $1K | Hold |
100
| – | – | ﹤0.01% | 4094 |
|
|
2015
Q4 | $1K | Sell |
100
-9,400
| -99% | -$94K | ﹤0.01% | 4155 |
|
|
2015
Q3 | $124K | Buy |
+9,500
| New | +$124K | ﹤0.01% | 1463 |
|